Events

EIT water: deep dive into the evaluation process
MAY
Wed
07
10:00 - 12:00

This was 5 months ago

Location

online

Programmes
Agro-Food, Environment EIT

At the beginning of the year, The European institute of innovation and technology (EIT) launched the call for a new EIT Knowledge and Innovation Community (KIC) in the water, marine and maritime sectors and ecosystems. A KIC is a community thet brings together people from the world of business, universities and research institutions. It will address global challenges including: water scarcity, droughts and floods as well as marine and freshwater degradation. 

Although the call is still open, The people at the EIT already want to provide a deep inisght into the evaluation process. This will take place online on the 7th of May in the morning. You can find all the details on this webpage

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.